Prudential Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-28,940
Closed -$124K 2526
2020
Q3
$124K Buy
28,940
+7,400
+34% +$30.9K ﹤0.01% 2351
2020
Q2
$97K Buy
21,540
+7,100
+49% +$31.7K ﹤0.01% 2337
2020
Q1
$58K Sell
14,440
-4,889
-25% -$41.5K ﹤0.01% 2300
2019
Q4
$164K Buy
+19,329
New +$151K ﹤0.01% 2343
2019
Q2
Sell
-13,394
Closed -$123K 2512
2019
Q1
$123K Buy
+13,394
New +$136K ﹤0.01% 2361
2018
Q4
Sell
-64,700
Closed -$903K 2477
2018
Q3
$903K Buy
64,700
+7,880
+14% +$107K ﹤0.01% 1894
2018
Q2
$605K Buy
56,820
+12,900
+29% +$126K ﹤0.01% 2010
2018
Q1
$379K Sell
43,920
-2,400
-5% -$21.1K ﹤0.01% 2083
2017
Q4
$437K Sell
46,320
-6,600
-12% -$51.6K ﹤0.01% 2051
2017
Q3
$415K Buy
52,920
+8,410
+19% +$63.1K ﹤0.01% 2065
2017
Q2
$383K Sell
44,510
-18,290
-29% -$131K ﹤0.01% 2090
2017
Q1
$443K Sell
62,800
-3,900
-6% -$24.4K ﹤0.01% 2058
2016
Q4
$283K Buy
66,700
+7,000
+12% +$33.9K ﹤0.01% 2168
2016
Q3
$297K Buy
59,700
+4,000
+7% +$16.9K ﹤0.01% 2137
2016
Q2
$197K Hold
55,700
﹤0.01% 2205
2016
Q1
$192K Buy
+55,700
New +$197K ﹤0.01% 2204

Other funds holding KIN

Prudential Financial's KIN Position: Q4 2020 in Review

Prudential Financial sold out of Kindred Biosciences, Inc. (KIN) in Q4 2020, closing a stake of 28,940 shares — an estimated $124K sold.

Prudential Financial first reported a position in KIN in Q1 2016 and held it in 16 quarters. The position peaked at $903K in Q3 2018. 82 funds tracked by Wall St. Rank hold KIN as of Q4 2020.

  • Prudential Financial reported no remaining Kindred Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Prudential Financial sold 28,940 Kindred Biosciences, Inc. shares in Q4 2020, an estimated $124K.
  • Prudential Financial first reported a position in Kindred Biosciences, Inc. in Q1 2016 and held it in 16 quarters.
  • Prudential Financial's Kindred Biosciences, Inc. position peaked at $903K in Q3 2018.
  • 82 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2020.

Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.